Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Introduction to Biologic and Biosimilar Product Development and Analysis - Karen M. Nagel

Introduction to Biologic and Biosimilar Product Development and Analysis

(Autor)

Buch | Hardcover
XI, 109 Seiten
2018 | 1st ed. 2018
Springer International Publishing (Verlag)
978-3-319-98427-8 (ISBN)
CHF 164,75 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery.   In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.

 

Karen Nagel is an Associate Professor of Pharmaceutics at Midwestern University Chicago College of Pharmacy where she has worked since 1999. She received her Ph.D in Industrial and Physical Pharmacy from Purdue University. Her current teaching responsibilities include required and elective courses in compounding, dosage form design, biotechnology, and the history of pharmacy. In order to increase their knowledge of and interest in careers in academia, she precepts several academic APPE rotation students per year. Dr. Nagel's primary areas of research are herbal product analysis and pharmaceutical compounding. She also has interests in biotechnology, dosage form design and educational research, and has contributed to several textbooks, review guides and encyclopedias. Dr. Nagel has been a member of AAPS since 1994 and has served on the planning committee of the local chapter, the Chicagoland Pharmaceutics Discussion Group, since 2002 (Treasurer, 2002-04; Chair, 2005-06). Dr. Nagel is a past chair (2010-11) of the APhA APRS Basic Sciences section, and has served on the APRS Awards, Education, and Policy committees. She has also been a member of AACP since 1999, serving as secretary of the Teachers of Pharmaceutics section (TOPS) from 2005-7 and as chair of the Laboratory SIG from 2004-5. She has served as an abstract and grant reviewer for AACP and APhA, and has moderated sessions at annual meetings for both groups. She also has served on the NABP Foreign Pharmacy Equivalency Exam Review Committee since 2003. Dr. Nagel serves on numerous college and university committees and is faculty advisor to the Midwestern University AAPS Student Chapter.

Recombinant DNA Technology.- Therapeutic Proteins.- Therapeutic Antibodies.- Analysis and Regulation of Biologics including Biosimilars.

Erscheinungsdatum
Reihe/Serie AAPS Introductions in the Pharmaceutical Sciences
Zusatzinfo XI, 109 p. 4 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 343 g
Themenwelt Medizin / Pharmazie Pharmazie PTA / PKA
Naturwissenschaften Chemie Technische Chemie
Technik
Schlagworte Biologics analysis • biologics regualtion • Recombinant DNA technology • Therapeutic Antibodies • Therapeutic proteins
ISBN-10 3-319-98427-6 / 3319984276
ISBN-13 978-3-319-98427-8 / 9783319984278
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Annina Bergner; Kirsten Seidel

Buch | Softcover (2024)
Deutscher Apotheker Verlag
CHF 55,70
Das Lehrbuch für Pharmazeutisch-kaufmännische Angestellte

von Martina Busch; Martina Schiffter-Weinle

Buch | Hardcover (2021)
Deutscher Apotheker Verlag
CHF 76,95
Wie Sie Ärzte, Apotheker, Patienten, Experten und Manager als Kunden …

von Günter Umbach

Buch | Softcover (2022)
Springer Fachmedien Wiesbaden GmbH (Verlag)
CHF 83,95